Loading...
•
Dec 31, 2024
Encompass Health Q4 2024 Earnings Report
Key Takeaways
Encompass Health reported strong Q4 2024 results, driven by a 12.7% increase in revenue and a 13.6% rise in Adjusted EBITDA. The company's discharge growth of 7.8% was a key driver of revenue expansion. Net income also saw a significant rise compared to the prior year.
Forward Guidance
Encompass Health expects continued revenue and earnings growth in 2025, driven by capacity expansion and increased patient volumes.
Positive Outlook
- Revenue guidance between $5.8 billion and $5.9 billion.
- Adjusted EBITDA projected to range from $1.16 billion to $1.2 billion.
- Earnings per share expected to be between $4.67 and $4.96.
- Continued expansion with new hospital additions.
- Strong operational execution and patient demand.
Challenges Ahead
- Higher cash tax payments expected.
- Labor and wage inflation could impact margins.
- Regulatory uncertainties in healthcare reimbursement.
- Capital expenditure requirements for hospital expansions.
- Potential macroeconomic headwinds affecting patient volumes.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...